Biologic Therapies and Autoimmune Phenomena

Alexandros A Drosos; Eleftherios Pelechas; Evripidis Kaltsonoudis; Theodora E Markatseli; Paraskevi V Voulgari

doi:10.31138/mjr.32.2.96

Biologic Therapies and Autoimmune Phenomena

Mediterr J Rheumatol. 2021 Jun 30;32(2):96-103. doi: 10.31138/mjr.32.2.96. eCollection 2021 Jun.

Authors

Alexandros A Drosos¹, Eleftherios Pelechas¹, Evripidis Kaltsonoudis¹, Theodora E Markatseli¹, Paraskevi V Voulgari¹

Affiliation

¹ Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece.

Abstract

The use of biologic medications has represented a great advancement in the treatment of autoimmune rheumatic diseases. Despite their excellent efficacy, during the last years, a growing number of reports of autoimmune phenomena and paradoxical inflammation has emerged. These phenomena may range from the discovery of an isolated autoantibody to full-blown autoimmune diseases, organ-specific and systemic. This review has been carried out in order to underline the multitude of the potential adverse manifestations from the use of biologic medications. Thus, early recognition of specific types of autoimmune phenomena is an imperative for the physicians allowing them to have an accurate diagnosis and treatment.

Keywords: Biologic agents; adverse events; autoimmune phenomena; paradoxical inflammation; treatment.

Publication types

Review